RIO DE JANEIRO, BRAZIL - Cuba s Finlay Vaccine Institute (IFV) reported Thursday the combination of two doses of its candidate vaccine Soberana 02 with a booster dose of Soberana Plus had shown 91.2% efficacy against SARS-CoV-2, which causes Covid-19.
Soberana 02 and Soberana Plus - developed by the IFV - are two of the five vaccine projects against the coronavirus being investigated by Cuban scientific institutions.
Preliminary analyses of the third and last phase of clinical trials of . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here
Covid pandemic — Seoul to impose stricter curbs, first Delta Plus case found in Israel msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Iran set to roll out homegrown coronavirus vaccine next week
Iran set to roll out homegrown coronavirus vaccine next week
Having recovered from 4th wave of COVID-19 with drop in new cases, fatalities, Iran has been slow in its vaccination drive
2021-05-31 18:12:24
TEHRAN, Iran
Iran is set to roll out its first indigenously developed vaccine for coronavirus, COV-Iran Barakat, next week after the third and final clinical trial.
Soberana-02 vaccine, jointly developed by Iran and Cuba, has also completed its third clinical trial and is ready for industrial line production.
Health Minister Saeed Namaki on Monday announced that the two homegrown vaccines were being mass-produced and would be administered to people starting next week.
Cuban legislators condemn U S embargo on Cuba - World News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
Saturday, 17 April 2021 10:03 PM
[ Last Update: Saturday, 17 April 2021 10:03 PM ] Iranian President Hassan Rouhani
Iranian President Hassan Rouhani says approximately 1.4 million doses of the COVID-19 vaccines will be administered in the country by Friday, in a bid to vaccinate high-risk groups.
“By [Friday], approximately 1.4 million vaccines will be injected, God willing,” Rouhani said in remarks on Friday.
He said the first high-risk group, which includes 7 to 8 million people older than 65, will be soon vaccinated in Iran.
After they are vaccinated, the president continued, “we will move ahead to the second [high-risk] group.”
“All the efforts are aimed at, God willing, importing vaccines and providing people with them … and then the people would be able to move on from this issue toward a more promising future,” he added.